WFRV-TV Local 5 - March 17, 2021
WFRV-TV Local 5 in Green Bay ran a story highlighting Aurora BayCare Medical Center's participation in a drug trial for COVID-19 pneumonia.
News Wise - Feb. 5, 2021
Michael Thompson, MD, PhD, oncologist and hematologist and investigator for Advocate Aurora Research Institute, co-authors a study on the use of convalescent plasma in patients with cancer.
Two Advocate Aurora sites will evaluate the effectiveness of the SIGNATERATM ctDNA test in detecting and monitoring residual disease in colorectal cancer patientsMarch 18, 2021
The study will take place at all 17 Wisconsin-based Advocate Aurora Health NCORP sites
March 16, 2021